OSI-930
10 mg
| 99.76%
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
OSI-930
50 mg
| 99.76%
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol
KN-93
10 mg
| 99.78%
TargetMol
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase.
More Information
Supplier Page